SUMO wrestling in the brain

Increasing the amount of SUMO, a small protein in the brain, could be a way of treating diseases such as epilepsy and schizophrenia, reveal scientists at the University of Bristol, UK. Their findings are published online today in Nature.

The brain contains about 100 million nerve cells, each having 10,000 connections to other nerves cells. These connections, called synapses, chemically transmit the information that controls all brain function via proteins called receptors. These processes are believed to be the basis of learning and memory.

A major feature of a healthy brain is that the synapses can modify how efficiently they work, by increasing or decreasing the amount of information transmitted. In disorders such as epilepsy the synapses transmit too much information, resulting in over-excitation in the cells.

The research team, led by Professor Jeremy Henley at Bristol University, has discovered that when one type of receptor – the kainate receptor – receives a chemical signal, a small protein called SUMO becomes attached to it. SUMO pulls the kainate receptor out of the synapse, preventing it from receiving information from other cells, thus making the cell less excitable.

Professor Henley said: “This work is important because it gives a new perspective and a deeper understanding of how the flow of information between cells in the brain is regulated. It is possible that increasing the amount of SUMO attached to kainate receptors – which would reduce communication between the cells – could be a way to treat epilepsy by preventing over-excitation.”

The discovery that SUMO proteins can regulate the way brain cells communicate may provide insight into the causes of, and treatments for, brain diseases that are characterised by too much synaptic activity. This discovery also provides new potential targets for drug development that could one day be used to treat a range of such disorders.

Source: University of Bristol

Related stories:

A breakthrough, then a surge, in stem cell research
Less than a year after a Wisconsin team helped discover a major alternative to human embryonic stem cells, the Madison scientists say more than 800 labs have begun using the approach, suggesting that many stem-cell researchers are starting to move beyond controversial embryonic sources for their work.
Lack of vitamin D linked to Parkinson's disease
A majority of Parkinson's disease patients had insufficient levels of vitamin D in a new study from Emory University School of Medicine.
Smell is 'noisy' and 'in shades of grey': Scientists debunk ancient lock-and-key theory
University of Manchester scientists have overturned the 2,500-year-old theory that smell is detected by simple lock-and-key codes – using maggots with only one working olfactory sensory neuron (OSN), a nose with one nerve cell.
Methamphetamine Enters Brain Quickly and Lingers
(PhysOrg.com) -- Using positron emission tomography (PET) to track tracer doses of methamphetamine in humans’ brains, scientists at the U.S. Department of Energy’s (DOE) Brookhaven National Laboratory find that the addictive and long-lasting effects of this increasingly prevalent drug can be explained in part by its pharmacokinetics — the rate at which it enters and clears the brain, and its distribution. This study in 19 healthy, non-drug-abusing volunteers includes a comparison with cocaine and also looked for differences by race. It will appear in the November 1, 2008, issue of Neuroimage.
Response to immune protein determines pathology of multiple sclerosis
New research may help reveal why different parts of the brain can come under attack in patients with multiple sclerosis (MS). According to a new study in mice with an MS-like disease, the brain's response to a protein produced by invading T cells dictates whether it's the spinal cord or cerebellum that comes under fire. The study—from researchers at the University of Maryland School of Medicine in Baltimore and Washington University in St. Louis—will be published online on October 13th in the Journal of Experimental Medicine.
Clue to genetic cause of fatal birth defect
A novel enzyme may play a major role in anencephaly, offering hope for a genetic test or even therapy for the rare fatal birth defect in which the brain fails to develop, according to a study from researchers at the University of Illinois at Chicago College of Medicine.
Vitamin D a key player in overall health of several body organs, says UC Riverside biochemist
Essential for life in higher animals, vitamin D, once linked to only bone diseases such as rickets and osteoporosis, is now recognized as a major player in contributing to overall human health, emphasizes UC Riverside's Anthony Norman, an international expert on vitamin D.
Mouse studies suggest daily dose of ginkgo may prevent brain cell damage after a stroke
Working with genetically engineered mice, researchers at Johns Hopkins have shown that daily doses of a standardized extract from the leaves of the ginkgo tree can prevent or reduce brain damage after an induced stroke.

News discussion:

Medicine & Health news